Want to join the conversation?
In 1Q16, $CSCO's deferred revenue had a solid double-digit growth of 10%, with product deferred revenue up 16% and service deferred revenue up 7%. Product deferred revenue driven by subscription and software businesses grew 36% in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?